STING-Dependent Signaling Underlies IL-10 Controlled Inflammatory Colitis

Overview of attention for article published in Cell Reports, December 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

news: 1 news outlet
twitter: 5 X users

patent: 14 patents

Readers on

mendeley: 149 Mendeley

So far, Altmetric has seen 14 patents that reference this research output.

FURTHER HETEROCYCLIC COMPOUNDS AS STING ANTAGONISTS AND THE USE THEREOF AS MEDICAMENT

Application WO-2025228899-A1

World Intellectual Property Organisation (WIPO)

06 Nov 2025

HETEROCYCLIC ACIDS AS STING ANTAGONISTS AND THE USE THEREOF AS MEDICAMENT

Application WO-2025228902-A1

World Intellectual Property Organisation (WIPO)

06 Nov 2025

ARYLAMIDE SUBSTITUTED INDAZOLES AND THE USE THEREOF AS MEDICAMENT

Application WO-2025228900-A1

World Intellectual Property Organisation (WIPO)

06 Nov 2025

MONOARYLIC HETEROCYCLIC COMPOUNDS AS STING ANTAGONISTS AND THE USE THEREOF AS MEDICAMENT

Application WO-2025228889-A1

World Intellectual Property Organisation (WIPO)

06 Nov 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 10 additional patents.